2018
DOI: 10.1007/s11882-018-0758-x
|View full text |Cite
|
Sign up to set email alerts
|

Progestogen Hypersensitivity

Abstract: The hypersensitivity symptoms are associated with exogenous progestin exposure (e.g., contraceptive medicines, in vitro fertilization therapy) or endogenous progesterone from progesterone surges during the luteal phase of the menstrual cycle and pregnancy. Recognition of this condition can be challenging to the clinician due to its heterogeneous clinical presentation. It has been recently proposed to use the new term "progestogen hypersensitivity" to replace "autoimmune progesterone dermatitis" due to the lack… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 40 publications
0
6
0
Order By: Relevance
“…Progesterone dermatitis (PD) is a skin disease due to progesterone toxicity, for example during the menstrual cycle [ 49 ]. Both PD and MHD develop in response to an endocrine disbalance or an external toxic stimulus, which explains their association in Figure 2 .…”
Section: Resultsmentioning
confidence: 99%
“…Progesterone dermatitis (PD) is a skin disease due to progesterone toxicity, for example during the menstrual cycle [ 49 ]. Both PD and MHD develop in response to an endocrine disbalance or an external toxic stimulus, which explains their association in Figure 2 .…”
Section: Resultsmentioning
confidence: 99%
“…One hundred twelve articles were found to include a case report meeting our inclusion criteria 3–114 . Within these articles, 132 unique cases of AIPD were identified.…”
Section: Resultsmentioning
confidence: 99%
“…Diagnosis is based on cutaneous eruptions related to increase in progesterone levels and may be confirmed by intracutaneous progesterone testing or progesterone-specific IgE serum. Other available but less useful diagnostic methods include: intramuscular progesterone injection, oral progesterone intake, patch testing (with a low negative predictive value), in vitro leukocyte histamine release assay and interferon-gamma-release assay (6). Clinical presentation is highly variable and includes all urticaria manifestations with or without angioedema, vesiculobullous, eczematous or purpuric lesions, as well as cutaneous eruptions resembling Stevens-Johnson syndrome, erythema multiforme or fixed drug eruptions (4); asthma and anaphylaxis may rarely accompany the symptoms (7).…”
Section: Discussionmentioning
confidence: 99%